|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.63 USD | -2.78% |
|
-5.11% | -42.37% |
| 05-13 | Ajax Therapeutics, Inc. announced that it has received $95 million in funding from a group of investors | CI |
| 05-07 | Ansys Partners With Schrodinger to Accelerate Materials Development | MT |
Ajax Therapeutics, Inc. announced that it will receive $95,000,000 in funding on April 26, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 878.4 USD | -0.55% | +3.35% | 791B | ||
| 446.5 USD | +0.02% | -1.86% | 152B | ||
| 20.63 USD | -2.78% | -5.11% | 1.5B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -42.37% | 1.5B | |
| +17.69% | 3,289B | |
| +14.62% | 90.43B | |
| +14.59% | 85.57B | |
| +37.27% | 52.49B | |
| -19.27% | 50.25B | |
| +32.93% | 46.79B | |
| +83.75% | 42.74B | |
| -32.70% | 41.67B | |
| -1.24% | 27.82B |
SCHRÖDINGER, INC. 
